Table 1.
Baseline demographic and clinical characteristics of PAD and control subjects
| Controls | PAD | |
|---|---|---|
| Number | 30 | 22 |
| Age, years | 53 ± 8 | 67 ± 10* |
| Race, % Caucasian | 63% | 73% |
| Sex (men/women) | 10/20 | 14/8 |
| Body mass index, kg/m2 | 27.3 ± 6.3 | 26.5 ±4.1 |
| Ankle-brachial index | 1.09 ±0.1 | 0.64 ± 0.2* |
| Past or current smoking, % | 29% | 90% |
| Aspirin use, % | 29% | 64%* |
| ACE inhibitor/ARB use, % | 3% | 45% |
| Statin use, % | 6% | 73% |
Values are mean ± SD or percentages.
*
p < 0.05 between control and PAD patients
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.